Clinical Research Directory
Browse clinical research sites, groups, and studies.
Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)
Sponsor: Sclnow Biotechnology Co., Ltd.
Summary
The purposes of the study is to determine the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating Myelodysplastic Syndrome patients.
Official title: Research for Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Myelodysplastic Syndrome (MDS)
Key Details
Gender
All
Age Range
60 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-12-31
Completion Date
2027-12-31
Last Updated
2026-04-23
Healthy Volunteers
No
Conditions
Interventions
Allogeneic umbilical cord mesenchymal stem cells
Experimental group receive Allogeneic umbilical cord mesenchymal stem cell，i.v (SCLnow 19#)
Decitabine
Decitabine，20mg/m\^2/d
Locations (1)
Inner Mongolia International Mongolian Hospital
Hohhot, Inner Mongolia, China